QQ客服 官方微博 反馈留言

	Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance    (Open Access)
	Yu, Miao; Han, Shangcong; Kou, Zhongai; Dai, Jialing; Liu, Jiao; Wei, Chen; Li, Yitong; Jiang, Lutao; Sun, Yong
刊名	Artificial Cells, Nanomedicine and Biotechnology
	2018
卷号	46期号:2页码:323-332
DOI	10.1080/21691401.2017.1307215
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4574080
专题	山东大学
作者单位	School of Pharmacy, Qingdao University, Qingdao,
推荐引用方式 GB/T 7714	Yu, Miao,Han, Shangcong,Kou, Zhongai,et al. Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance    (Open Access)[J]. Artificial Cells, Nanomedicine and Biotechnology,2018,46(2):323-332.
APA	Yu, Miao.,Han, Shangcong.,Kou, Zhongai.,Dai, Jialing.,Liu, Jiao.,...&Sun, Yong.(2018).Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance    (Open Access).Artificial Cells, Nanomedicine and Biotechnology,46(2),323-332.
MLA	Yu, Miao,et al."Lipid nanoparticle-based co-delivery of epirubicin and BCL-2 siRNA for enhanced intracellular drug release and reversing multidrug resistance    (Open Access)".Artificial Cells, Nanomedicine and Biotechnology 46.2(2018):323-332.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。